Records containing: Recurrent Cervical Carcinoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-23
A Multicenter Phase 2 Study to Evaluate Efficacy and Safety of PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer.
CLINICAL_TRIALS study record update · 2026-04-13
Molecular Analysis for Therapy Choice (MATCH)
CLINICAL_TRIALS study record update · 2026-03-18
Pilot Feasibility Study of Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
CLINICAL_TRIALS study record update · 2026-03-12
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
CLINICAL_TRIALS study record update · 2026-03-11
Phase I Study of Talazoparib in Combination With Radiation Therapy for Locally Recurrent Gynecologic Cancers
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2026-01-13
A Phase 2 Study of Dostarlimab in Combination With Cobolimab in Advanced Cervical Cancer
CLINICAL_TRIALS study record update · 2025-10-27
Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer
CLINICAL_TRIALS study record update · 2025-05-31
A Phase 1 Study of Durvalumab, Tremelimumab and Radiotherapy in Recurrent Gynecologic Cancer
CLINICAL_TRIALS study record update · 2025-05-22
Phase Ib Clinical Investigation of Intraperitoneal Ipilimumab and Nivolumab in Patients With Peritoneal Carcinomatosis Due to Gynecologic Cancers
CLINICAL_TRIALS study record update · 2024-07-09
A Phase 2, Open-Label Study to Evaluate Efficacy of Combination Treatment With MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients With Recurrent/Metastatic Human Papilloma Virus Associated Cancers
CLINICAL_TRIALS study record update · 2023-09-13
Phase I Multi-Center Study of Hypofractionated Radiotherapy in Combination With Durvalumab and Tremelimumab in Patients With Recurrent/Metastatic Advanced Cervical, Vaginal, or Vulvar Cancer
CLINICAL_TRIALS study record update · 2023-06-26
MRI- and PET-Predictive-Assay of Treatment Outcome in Cancer of the Cervix
CLINICAL_TRIALS study record update · 2023-06-06
A Phase I Study of the Wee 1 Kinase (Wee 1) Inhibitor AZD1775 in Combination With Radiotherapy and Cisplatin in Cervical, Upper Vaginal and Uterine Cancers (10041848, 10008224, 10008238, 10046888, 10014735)
CLINICAL_TRIALS study record update · 2023-04-11
SHR-1210, a Novel Anti-pd-1 Antibody, in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer: a Single-arm, Open Label, Multi-center, Phase II Study
CLINICAL_TRIALS study record update · 2023-02-21
A Phase 2 Study of Atezolizumab (MPDL3280A) in Combination With Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer
CLINICAL_TRIALS study record update · 2022-11-08
A Phase 2 Study of Ipilimumab in Women With Metastatic or Recurrent HPV-Related Cervical Carcinoma of Either Squamous Cell or Adenocarcinoma Histologies
CLINICAL_TRIALS study record update · 2022-04-11
Combination of Immune Checkpoint Inhibitors Tislelizumab and Radiotherapy for Recurrent, Metastatic and Persistent Advanced Cervical Cancer: A Single-arm, Single-center, Phase 2 Clinical Study
CLINICAL_TRIALS study record update · 2022-04-11
Combination of Immune Checkpoint Inhibitors PD-1 Monoclonal Antibody and Radiotherapy for Recurrent, Metastatic and Persistent Advanced Cervical Cancer: A Retrospective Cohort Study
CLINICAL_TRIALS study record update · 2022-04-04
Efficacy and Safety of Donafenib Combined With Paclitaxel and Platinum in Patients With Recurrent, Metastatic, and Persistent Advanced Cervical Cancer: A Single-arm, Phase II Study
CLINICAL_TRIALS study record update · 2022-03-22
Anti-PD-1 Antibody Camrelizumab Combined With Albumin-bound Paclitaxel for Recurrent and Persistent Advanced Cervical Cancer Refractory to Platinum-based Chemotherapy: A Single Arm, Multi-Center, Open, Phase II Trial
CLINICAL_TRIALS study record update · 2022-03-15
Apatinib Combined With Cisplatin and Paclitaxel as First-line Chemotherapy for Recurrent or Persistent Advanced Cervical Cancer: A Single Arm, Single Center, Open, Phase II Trial
CLINICAL_TRIALS study record update · 2022-03-15
Anti-PD-1 Antibody Camrelizumab Combined With Albumin-bound Paclitaxel for Recurrent and Persistent Advanced Cervical Cancer Refractory to Platinum-based Chemotherapy: A Single Arm, Single Center, Open, Phase II Trial
CLINICAL_TRIALS study record update · 2020-12-22
Combination of Nimotuzumab and Radiotherapy for Recurrent and Metastatic Uterine Cervical Squamous Carcinoma: a Single-arm, Open, Phase 2 Clinical Trial
CLINICAL_TRIALS study record update · 2020-11-19
Anti-PD-1 Antibody Camrelizumab Combined With Cisplatin/Paclitaxel/Bevacizumab for Recurrent or Advanced Cervical Neuroendocrine Carcinomas: A Single Arm, Phase II Trial
CLINICAL_TRIALS study record update · 2020-09-11
A Phase II Evaluation of ADXS11-001 (NSC 752718) in the Treatment of Persistent or Recurrent Squamous or Non-Squamous Cell Carcinoma of the Cervix